Clinical Trial Update: Safety and Efficacy Study of Asfotase Alfa in Adolescents and Adults With Hypophosphatasia (HPP) [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating safety and efficacy of asfotase alfa in adolescents and adults with hypophosphatasia has completed with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypophosphatasia

Drugs mentioned

• Asfotase alfa (asfotase alfa)

Snippet

Sponsor: Alexion Pharmaceuticals, Inc. | Conditions: Hypophosphatasia | Phase 2 | Status: COMPLETED | Results posted: 2017-09-18